Literature DB >> 3402560

Opiate binding differentially associated with oxytocin and vasopressin nerve endings from porcine neurohypophyses.

N Falke1, R Martin.   

Abstract

We examined opioid binding in fractions with disconnected nerve endings (secretosomes) which were prepared from porcine neurohypophyses by centrifugation in a discontinuous Percoll gradient. Specific (= displaceable) binding was observed with 3H-etorphine and with 3H-diprenorphine, two ligands with low selectivity for distinct opiate receptor subclasses. No displaceable binding was found with the prototypic mu- and delta-ligands 3H-dihydromorphine and 3H-(D-Ala, D-Leu) enkephalin. Displacement of 3H-diprenorphine binding was almost absent with the selective mu- and delta-ligands morphiceptin and ICI-174864. Partial displacement occurred with the selective kappa-ligand U-50488 and with dynorphin. Binding of 3H-etorphine was stereo-specific. 3H-diprenorphine binding was saturable with a KD between 2 and 4 nM. Maximum of opiate binding activity was detected in the fractions with accumulated secretosomes. By autoradiography specific 3H-diprenorphine binding is shown to be mainly associated with secretosomes. In imunocytochemical preparations an oxytocin antibody was immunoreactive in 85% of the secretosomes in the fraction with highest opiate binding. These fractions in radioimmunoassays exhibited the largest contents in oxytocin and low vasopressin levels. The data therefore suggest that in the porcine neurohypophysis opioid binding sites of the kappa-type occur in secretory endings presumably of the oxytocin type.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3402560     DOI: 10.1007/bf00271856

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  29 in total

1.  Neurohypophysial opioids and oxytocin secretion: source of inhibitory opioids.

Authors:  R J Bicknell; C Chapman; G Leng
Journal:  Exp Brain Res       Date:  1985       Impact factor: 1.972

2.  Dynorphin and dynorphin are ligands for the kappa-subtype of opiate receptor.

Authors:  A D Corbett; S J Paterson; A T McKnight; J Magnan; H W Kosterlitz
Journal:  Nature       Date:  1982-09-02       Impact factor: 49.962

3.  Dynorphin and vasopressin: common localization in magnocellular neurons.

Authors:  S J Watson; H Akil; W Fischli; A Goldstein; E Zimmerman; G Nilaver; T B van wimersma Griedanus
Journal:  Science       Date:  1982-04-02       Impact factor: 47.728

4.  A simplified method of "hypothetical grain" analysis of electron microscope autoradiographs.

Authors:  N M Blackett; D M Parry
Journal:  J Histochem Cytochem       Date:  1977-03       Impact factor: 2.479

5.  ICI 174864: a highly selective antagonist for the opioid delta-receptor.

Authors:  R Cotton; M G Giles; L Miller; J S Shaw; D Timms
Journal:  Eur J Pharmacol       Date:  1984-01-27       Impact factor: 4.432

6.  Evidence for opiate receptors on pituicytes.

Authors:  S L Lightman; M Ninkovic; S P Hunt; L L Iversen
Journal:  Nature       Date:  1983 Sep 15-21       Impact factor: 49.962

7.  U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist.

Authors:  P F Vonvoigtlander; R A Lahti; J H Ludens
Journal:  J Pharmacol Exp Ther       Date:  1983-01       Impact factor: 4.030

8.  Morphiceptin (NH4-tyr-pro-phe-pro-COHN2): a potent and specific agonist for morphine (mu) receptors.

Authors:  K J Chang; A Lillian; E Hazum; P Cuatrecasas; J K Chang
Journal:  Science       Date:  1981-04-03       Impact factor: 47.728

9.  Do opioid peptides modulate, at the level of the nerve endings, the release of neurohypophysial hormones?

Authors:  J J Nordmann; G Dayanithi; M Cazalis
Journal:  Exp Brain Res       Date:  1986       Impact factor: 1.972

10.  A simple method for removing the resin from epoxy-embedded tissue.

Authors:  H D MAYOR; J C HAMPTON; B ROSARIO
Journal:  J Biophys Biochem Cytol       Date:  1961-04
View more
  3 in total

Review 1.  Coexisting peptides in hypothalamic neuroendocrine systems: some functional implications.

Authors:  C A Bondy; M H Whitnall; L S Brady; H Gainer
Journal:  Cell Mol Neurobiol       Date:  1989-12       Impact factor: 5.046

2.  Immunoreactive galanin-like material in magnocellular hypothalamo-neurohypophysial neurones of the rat.

Authors:  W Gaymann; R Martin
Journal:  Cell Tissue Res       Date:  1989-01       Impact factor: 5.249

3.  Intracellular calcium and hormone release from nerve endings of the neurohypophysis in the presence of opioid agonists and antagonists.

Authors:  G Dayanithi; E L Stuenkel; J J Nordmann
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.